LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | PI103 | 0.37 | uM | LJP6 | 1 | I16 | 72 | hr | 868 | 2245 | 3486 | 0.6439 | 0.5259 |
MDA-MB-231 | PI103 | 0.37 | uM | LJP6 | 2 | I16 | 72 | hr | 868 | 2248 | 3486 | 0.6448 | 0.5270 |
MDA-MB-231 | PI103 | 0.37 | uM | LJP6 | 3 | I16 | 72 | hr | 868 | 2185 | 3486 | 0.6267 | 0.5030 |
MDA-MB-231 | PLX-4720 | 0.37 | uM | LJP5 | 1 | K04 | 72 | hr | 868 | 3520 | 3486 | 1.0096 | 1.0128 |
MDA-MB-231 | PLX-4720 | 0.37 | uM | LJP5 | 2 | K04 | 72 | hr | 868 | 3729 | 3486 | 1.0696 | 1.0927 |
MDA-MB-231 | PLX-4720 | 0.37 | uM | LJP5 | 3 | K04 | 72 | hr | 868 | 3236 | 3486 | 0.9282 | 0.9044 |
MDA-MB-231 | QL-X-138 | 0.37 | uM | LJP6 | 1 | F22 | 72 | hr | 868 | 2593 | 3486 | 0.7438 | 0.6588 |
MDA-MB-231 | QL-X-138 | 0.37 | uM | LJP6 | 2 | F22 | 72 | hr | 868 | 2811 | 3486 | 0.8063 | 0.7421 |
MDA-MB-231 | QL-X-138 | 0.37 | uM | LJP6 | 3 | F22 | 72 | hr | 868 | 2581 | 3486 | 0.7403 | 0.6542 |
MDA-MB-231 | QL-XII-47 | 0.37 | uM | LJP6 | 1 | O22 | 72 | hr | 868 | 1283 | 3486 | 0.3680 | 0.1585 |
MDA-MB-231 | QL-XII-47 | 0.37 | uM | LJP6 | 2 | O22 | 72 | hr | 868 | 1453 | 3486 | 0.4168 | 0.2234 |
MDA-MB-231 | QL-XII-47 | 0.37 | uM | LJP6 | 3 | O22 | 72 | hr | 868 | 1592 | 3486 | 0.4566 | 0.2765 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP5 | 1 | K10 | 72 | hr | 868 | 1452 | 3486 | 0.4165 | 0.2230 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP5 | 2 | K10 | 72 | hr | 868 | 1581 | 3486 | 0.4535 | 0.2723 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP5 | 3 | K10 | 72 | hr | 868 | 1424 | 3486 | 0.4084 | 0.2123 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP6 | 1 | K10 | 72 | hr | 868 | 1613 | 3486 | 0.4627 | 0.2845 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP6 | 2 | K10 | 72 | hr | 868 | 1674 | 3486 | 0.4802 | 0.3078 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP6 | 3 | K10 | 72 | hr | 868 | 1752 | 3486 | 0.5025 | 0.3376 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 1 | J04 | 72 | hr | 868 | 3016 | 3486 | 0.8651 | 0.8203 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 2 | J04 | 72 | hr | 868 | 3136 | 3486 | 0.8995 | 0.8662 |
MDA-MB-231 | Seliciclib | 0.37 | uM | LJP5 | 3 | J04 | 72 | hr | 868 | 3031 | 3486 | 0.8694 | 0.8261 |
MDA-MB-231 | Ruxolitinib | 0.37 | uM | LJP5 | 1 | O16 | 72 | hr | 868 | 2971 | 3486 | 0.8522 | 0.8032 |
MDA-MB-231 | Ruxolitinib | 0.37 | uM | LJP5 | 2 | O16 | 72 | hr | 868 | 3411 | 3486 | 0.9784 | 0.9712 |
MDA-MB-231 | Ruxolitinib | 0.37 | uM | LJP5 | 3 | O16 | 72 | hr | 868 | 2938 | 3486 | 0.8427 | 0.7906 |
MDA-MB-231 | XL147 | 0.37 | uM | LJP5 | 1 | G10 | 72 | hr | 868 | 3608 | 3486 | 1.0349 | 1.0464 |